{
 "awd_id": "9261362",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "Noninvasive Measurement of Body Composition",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Kesh S. Narayanan",
 "awd_eff_date": "1993-01-01",
 "awd_exp_date": "1993-09-30",
 "tot_intn_awd_amt": 49852.0,
 "awd_amount": 49852.0,
 "awd_min_amd_letter_date": "1992-12-23",
 "awd_max_amd_letter_date": "1992-12-23",
 "awd_abstract_narration": "The ability to measure body                                                     composition, as reflected in                                                    body fat percentage, is essential                                               for diagnosis, treatment,                                                       and research investigation related                                              to obesity, malnutrition,                                                       eating disorders, diabetes, heart                                               disease, athletic                                                               training, and physical fitness.  A                                              method for body                                                                 composition measurement which                                                   brings Archimedes' principle                                                    \"on dry land\" will be developed.                                                Rather than determining                                                         the volume of subjects by immersion                                             in water, the                                                                   differential buoyancy acting on                                                 subjects in safely                                                              breathable atmospheres which differ                                             in density will be                                                              determined.  This method will not                                               require the cooperation of                                                      the patient and does not require                                                the measurement of residual                                                     lung volume.  Furthermore, it is                                                independent of the                                                              distribution pattern of fat and                                                 does not require calibration                                                    against another method.  This Phase                                             I project is aimed at                                                           optimizing the precision, speed,                                                and reliability of the                                                          method through automation of the                                                measurement process.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Beth",
   "pi_last_name": "Schrope",
   "pi_mid_init": "",
   "pi_sufx_name": "",
   "pi_full_name": "Beth Schrope",
   "pi_email_addr": "",
   "nsf_id": "000194378",
   "pi_start_date": "1993-01-01",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "RESHET Inc",
  "inst_street_address": "401 City Avenue",
  "inst_street_address_2": "Suite 200",
  "inst_city_name": "Bala Cynwyd",
  "inst_state_code": "PA",
  "inst_state_name": "Pennsylvania",
  "inst_phone_num": "2152229117",
  "inst_zip_code": "",
  "inst_country_name": "United States",
  "cong_dist_code": "",
  "st_cong_dist_code": "PA",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": null
 },
 "perf_inst": {
  "perf_inst_name": "DATA NOT AVAILABLE",
  "perf_str_addr": "",
  "perf_city_name": "",
  "perf_st_code": "",
  "perf_st_name": "RI REQUIRED",
  "perf_zip_code": "",
  "perf_ctry_code": "",
  "perf_cong_dist": "",
  "perf_st_cong_dist": "",
  "perf_ctry_name": "",
  "perf_ctry_flag": "0"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537100",
   "pgm_ele_name": "SBIR Phase I"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "5345",
   "pgm_ref_txt": "BIOMEDICAL ENGINEERING"
  },
  {
   "pgm_ref_code": "5371",
   "pgm_ref_txt": "SMALL BUSINESS PHASE I"
  },
  {
   "pgm_ref_code": "9126",
   "pgm_ref_txt": "BIOTECHNOLOGY INSTRUMENTATION"
  }
 ],
 "app_fund": [
  {
   "app_code": "",
   "app_name": "",
   "app_symb_id": "",
   "fund_code": "",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 1993,
   "fund_oblg_amt": 49852.0
  }
 ],
 "por": null
}